NCT03142412View on ClinicalTrials.gov

Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization

UnknownOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

October 17, 2021

Study Completion Date

October 17, 2021

Conditions
Systemic Lupus ErythematosusLupusLupus ErythematosusLupus Erythematosus, Systemic
Trial Locations (1)

90220

DxTerity Diagnostics, Compton

Sponsors
All Listed Sponsors
lead

DxTerity Diagnostics

INDUSTRY

NCT03142412 - Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization | Biotech Hunter | Biotech Hunter